CULLEN/FROST BANKERS, INC. - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.

Quarter-by-quarter ownership
CULLEN/FROST BANKERS, INC. ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,340
-23.4%
5000.0%0.00%
Q2 2023$20,035
-1.8%
5000.0%0.00%
Q1 2023$20,405
+5.7%
5000.0%0.00%
Q4 2022$19,305
-28.5%
5000.0%0.00%
-100.0%
Q3 2022$27,000
-6.9%
5000.0%0.00%0.0%
Q2 2022$29,000
-23.7%
5000.0%0.00%0.0%
Q1 2022$38,000
+26.7%
5000.0%0.00%0.0%
Q4 2021$30,000
+7.1%
5000.0%0.00%0.0%
Q3 2021$28,000
-6.7%
5000.0%0.00%0.0%
Q2 2021$30,000
-14.3%
5000.0%0.00%0.0%
Q1 2021$35,000
+16.7%
5000.0%0.00%0.0%
Q4 2020$30,0000.0%5000.0%0.00%0.0%
Q3 2020$30,000
+15.4%
5000.0%0.00%0.0%
Q2 2020$26,000
+52.9%
5000.0%0.00%0.0%
Q1 2020$17,000
-26.1%
5000.0%0.00%0.0%
Q4 2019$23,000
+21.1%
5000.0%0.00%0.0%
Q3 2019$19,000
-13.6%
5000.0%0.00%0.0%
Q2 2019$22,000
+15.8%
5000.0%0.00%0.0%
Q1 2019$19,000
-91.1%
500
-77.3%
0.00%
-88.9%
Q3 2014$213,0002,2000.01%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 563,415$21,753,4534.80%
Gagnon Advisors, LLC 180,331$6,962,5794.70%
Spyglass Capital Management LLC 868,686$33,539,9662.69%
Tamarack Advisers, LP 100,000$3,861,0001.99%
ARMISTICE CAPITAL, LLC 1,892,000$73,050,1201.27%
NEUMEIER POMA INVESTMENT COUNSEL LLC 276,590$10,679,1400.99%
RICE HALL JAMES & ASSOCIATES, LLC 437,285$16,883,5740.97%
Rock Springs Capital Management LP 1,032,600$39,868,6860.96%
OUTFITTER FINANCIAL LLC 25,860$998,4550.91%
Stephens Investment Management Group LLC 1,168,469$45,535,2370.82%
View complete list of PACIRA PHARMACEUTICALS INC shareholders